Ascendis Pharma wins FDA approval for navepegritide for achondroplasia
Oil jumps as market sees rising risk of U.S.-Iran conflict
Delta continues fleet renewal, ordering another 34 Airbus jets
Business
Via targets 25%+ revenue growth and first profitable quarter in Q4 2026 amid AI-driven product expansion
Fulgent Genetics forecasts $350M 2026 revenue and 53% AP growth as Bako, StrataDx acquisitions reshape customer mix
ALX Oncology outlines pivotal trial readiness by end of 2026 with expanded ASPEN-09 study and $150M financing
RLJ Lodging Trust targets 0.5%–3% RevPAR growth for 2026 amid urban market momentum and capital allocation flexibility
Hawaiian Electric signals $550M–$700M capex for 2026 as wildfire settlements near final approval
Gold, silver cap historic month with best-ever dollar gains; U.S.-Iran tensions in focus
Greencastle to raise up to $200,000 in private placement, names new CEO
Calumet targets MaxSAF 150 expansion and $1–$2/gallon SAF contract premiums as operational gains drive leverage reduction
Business